The STAT1/HMGB1/NF-κB pathway in chronic inflammation and kidney injury after cisplatin exposure

These results unravel the STAT1/HMGB1/NF-κB pathway that contributes to persistent inflammation and chronic kidney problems after cisplatin nephrotoxicity, suggesting new therapeutic targets for kidney protection in cancer patients receiving cisplatin chemotherapy.